Padma 1994.

Methods	Randomized controlled trial Duration: dates not specified. Participants followed up for 3 months
Participants	Number: 75 enrolled (52 male, 23 female) Inclusion criteria: adults and children aged 3.5 to 50 years with epilepsy, parenchymal single small enhancing lesions Exclusion criteria: neurological deficit on examination Type of lesion: non‐viable
Interventions	Group 1. Albendazole: 15 mg per kg per day for 7 days Group 2. Placebo
Outcomes	Included in the review: complete resolution, partial resolution, and no resolution of lesion at 1 week, 1 month and 3 months
Notes	Location: India Source of funding: not stated
Risk of bias
Bias	Authors' judgement	Support for judgement
Adequate sequence generation?	Unclear risk	Quote: "Patients were randomly allocated to placebo or albendazole therapy" Decision: unclear, probably done
Allocation concealment?	Unclear risk	Not described Decision: unclear
Blinding? All outcomes	Low risk	Quote: "CTs were assessed by a neuroradiologist who was not aware of the treatment received by the patient" Placebos were used for participants Decision: done
Incomplete outcome data addressed? All outcomes	Low risk	75 participants randomized, follow‐up data at 3 months available for 68 (91%)
Free of selective reporting?	Low risk	No evidence of selective reporting
Free of other bias?	Low risk	No evidence of other bias